PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas

Junling Shen; Jilong Yang; Lei Sang; Rui Sun; Weiyu Bai; Chao Wang; Yan Sun; Jianwei Sun

doi:10.20892/j.issn.2095-3941.2020.0294

Article Information

vol. 19 no. 8 1211-1223

DOI

https://doi.org/10.20892/j.issn.2095-3941.2020.0294

Published By

Cancer Biology & Medicine

History

Received July 14, 2020
Accepted October 26, 2020
Published online August 29, 2022.

Article Versions

previous version (July 15, 2022 - 07:16).
You are viewing the most recent version of this article.

Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

Junling Shen1,*,
Jilong Yang2,*,
Lei Sang1,
Rui Sun1,
Weiyu Bai1,
Chao Wang2,
Yan Sun2 ⇑ and
Jianwei Sun1 ⇑

¹Center for Life Sciences, School of Life Sciences, State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, Yunnan University, Kunming 650091, China
²Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China